REFERENCES
- Moldin S O. Report of NIMH Genetics Workgroup: summary of research. Biol Psychiatry 1999; 45: 573–602, [CSA]
- Harrison P J, Weinberger D R. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 2005; l10: 40–68, image 5[CROSSREF], [CSA]
- Caspi A, Sugden K, Moffitt T E, et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003; 301: 386–9, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Hattori E, Liu C, Badner J A, et al. Polymorphisms at the G72/G30 gene locus, on 13q33, are associated with bipolar disorder in two independent pedigree series. Am J Hum Genet 2003; 72: 1131–40, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Fraser F C. Genetic counseling. Am J Hum Genet 1974; 26: 636–61, [PUBMED], [INFOTRIEVE], [CSA]
- Merikangas K R, Risch N. Will the genomics revolution revolutionize psychiatry?. Am J Psychiatry 2003; 160: 625–35, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry 2002; 159: 1–50, [CROSSREF], [CSA]
- Quaid K A, Aschen S R, Smiley C L, Nurnberger J I. Perceived genetic risks for bipolar disorder in a patient population: an exploratory study. J Genet Couns 2001; 10: 41–51, [CROSSREF], [CSA]
- Trippitelli C L, Jamison K R, Folstein M F, Bartko J J, De Paulo J R. Pilot study on patients' and spouses' attitudes toward potential genetic testing for bipolar disorder. Am J Psychiatry 1998; 155: 899–904, [PUBMED], [INFOTRIEVE], [CSA]
- Smith L B, Sapers B, Reus V I, Freimer N B. Attitudes towards bipolar disorder and predictive genetic testing among patients and providers. J Med Genet 1996; 33: 544–9, [PUBMED], [INFOTRIEVE], [CSA]
- Jones I, Scourfield J, McCandless F, Craddock N. Attitudes towards future testing for bipolar disorder susceptibility genes: a preliminary investigation. J Affect Disord 2002; l71: 189–93, [CROSSREF], [CSA]
- Milner K K, Collins E E, Connors G R, Petty E M. Attitudes of young adults to prenatal screening and genetic correction for human attributes and psychiatric conditions. Am J Med Genet 1998; 76: 111–9, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Milner K K, Han T, Petty E M. Support for the availability of prenatal testing for neurological and psychiatric conditions in the psychiatric community. Genet Test 1999; 3: 279–86, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Meiser B, Mitchell P B, McGirr H, Van Herten M, Schofield P R. Implications of genetic risk information in families with a high density of bipolar disorder: an exploratory study. Soc Sci Med 2005; 60: 109–18, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Palmour R M. Genetic counselling for affective disease. Psychiatr J Univ Ott 1989; l14: 323–7, discussion 349–51[CSA]
- Tsuang M T. Genetic counseling for psychiatric patients and their families. Am J Psychiatry 1978; 135: 1465–75, [PUBMED], [INFOTRIEVE], [CSA]
- Faraone S V, Tsuang M T, Tsuang D W. Genetics of mental disorders: a guide for students, clinicians, and researchers. Guilford, New York 1999
- Bassett A S, Chow E W. 22q11 deletion syndrome: a genetic subtype of schizophrenia. Biol Psychiatry 1999; 46: 882–91, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Cassidy S B, Morris C A. Behavioral phenotypes in genetic syndromes: genetic clues to human behavior. Adv Pediatr 2002; 49: 59–86, [PUBMED], [INFOTRIEVE], [CSA]
- Estrov Y, Scaglia F, Bodamer O A. Psychiatric symptoms of inherited metabolic disease. J Inherit Metab Dis 2000; l23: 2–6, [CROSSREF], [CSA]
- Golomb M. Psychiatric symptoms in metabolic and other genetic disorders: is our “organic” workup complete?. Harv Rev Psychiatry 2002; 10: 242–8, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Hodgkinson K A, Murphy J, O'Neill S, Brzustowicz L, Bassett A S. Genetic counselling for schizophrenia in the era of molecular genetics. Can J Psychiatry 2001; 46: 123–30, [PUBMED], [INFOTRIEVE], [CSA]
- Holland A J, Whittington J E, Butler J, Webb T, Boer H, Clarke D. Behavioural phenotypes associated with specific genetic disorders: evidence from a population-based study of people with Prader-Willi syndrome. Psychol Med 2003; l33: 141–53, [CROSSREF], [CSA]
- Moldavsky M, Lev D, Lerman-Sagie T. Behavioral phenotypes of genetic syndromes: a reference guide for psychiatrists. J Am Acad Child Adolesc Psychiatry 2001; 40: 749–61, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Lyon G, Adams R D, Kolodny E H. Neurology of hereditary metabolic diseases of children. McGraw-Hill, Health Professions Division, New York 1996
- Neill J. Whatever became of the schizophrenogenic mother?. Am J Psychother 1990; 44: 499–505, [PUBMED], [INFOTRIEVE], [CSA]
- Fromm-Reichmann F. Notes on the development of treatment of schizophrenics by psychoanalytic psychotherapy. Psychiatry 1948; 11: 263–273, [CSA]
- Austin J C, Honer W G. The potential impact of genetic counseling for mental illness. Clin Genet 2005; 67: 134–42, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Schulz P M, Schulz S C, Dibble E, Targum S D, van Kammen D P, Gershon E S. Patient and family attitudes about schizophrenia: implications for genetic counseling. Schizophr Bull 1982; 8: 504–13, [PUBMED], [INFOTRIEVE], [CSA]
- Targum S D, Dibble E D, Davenport Y B, Gershon E S. The Family Attitudes Questionnaire. Patients' and spouses' views of bipolar illness. Arch Gen Psychiatry 1981; 38: 562–8, [PUBMED], [INFOTRIEVE], [CSA]
- Smoller J W, Finn C T. Family, twin, and adoption studies of bipolar disorder. Am J Med Genet C Semin Med Genet 2003; 123: 48–58, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Kessler R C, Demler O, Frank R G, et al. Prevalence and treatment of mental disorders, 1990 to 2003. N Engl J Med 2005; l352: 2515–23, [CROSSREF], [CSA]
- Weissman M M, Bland R C, Canino G J, et al. Cross-national epidemiology of major depression and bipolar disorder. JAMA 1996; 276: 293–9, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Cannon T D, Huttunen M O, Dahlstrom M, Larmo I, Rasanen P, Juriloo A. Antipsychotic drug treatment in the prodromal phase of schizophrenia. Am J Psychiatry 2002; 159: 1230–2, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- McGlashan T H, Zipursky R B, Perkins D, et al. The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. I. Study rationale and design. Schizophr Res 2003; 61: 7–18, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Phillips L J, Yung A R, Yuen H P, Pantelis C, McGorry P D. Prediction and prevention of transition to psychosis in young people at incipient risk for schizophrenia. Am J Med Genet 2002; 114: 929–37, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Tsuang M T, Stone W S, Faraone S V. Understanding predisposition to schizophrenia: toward intervention and prevention. Can J Psychiatry 2002; 47: 518–26, [PUBMED], [INFOTRIEVE], [CSA]
- Roberts J S. Anticipating response to predictive genetic testing for Alzheimer's disease: a survey of first-degree relatives. Gerontologist 2000; 40: 43–52, [PUBMED], [INFOTRIEVE], [CSA]
- Peay H, McInerney J. A pilot study on psychiatric genetic counseling: counselor's needs. J Genet Couns 2002; l11: 485, [CSA]
- Finn C T, Wilcox M A, Korf B R, et al. Psychiatric genetics: a survey of psychiatrists' knowledge, opinions, and practice patterns. J Clin Psychiatry 2005; 66: 821–30, [PUBMED], [INFOTRIEVE], [CSA]
- Hofman K J, Tambor E S, Chase G A, Geller G, Faden R R, Holtzman N A. Physicians' knowledge of genetics and genetic tests. Acad Med 1993; 68: 625–32, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Taylor M R. A survey of chairpersons of departments of medicine about the current and future roles of clinical genetics in internal medicine. Genet Med 2003; 5: 328–31, [PUBMED], [INFOTRIEVE], [CSA]
- Wilkins-Haug L, Hill L D, Power M L, Holzman G B, Schulkin J. Gynecologists' training, knowledge, and experiences in genetics: a survey. Obstet Gynecol 2000; 95: 421–4, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Firth H V, Lindenbaum R H. UK clinicians' knowledge of and attitudes to the prenatal diagnosis of single gene disorders. J Med Genet 1992; 29: 20–3, [PUBMED], [INFOTRIEVE], [CSA]
- Geller G, Tambor E S, Chase G A, Hofman K J, Faden R R, Holtzman N A. Incorporation of genetics in primary care practice. Will physicians do the counseling and will they be directive? Arch Fam Med 1993; 2: 1119–25, [CSA]
- Marteau T M. Communicating genetic risk information. Br Med Bull 1999; 55: 414–28, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Carnevale A, Lisker R, Villa A R, Casanueva E, Alonso E. Counselling following diagnosis of a fetal abnormality: comparison of different clinical specialists in Mexico. Am J Med Genet 1997; 69: 23–8, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Mahowald M B, Verp M S, Anderson R R. Genetic counseling: clinical and ethical challenges. Annu Rev Genet 1998; 32: 547–59, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Clarke A. Is non-directive genetic counselling possible?. Lancet 1991; 338: 998–1001, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Kessler S. Psychological aspects of genetic counseling. XI. Nondirectiveness revisited. Am J Med Genet 1997; l72: 164–71, [CROSSREF], [CSA]
- Bennett R L, Steinhaus K A, Uhrich S B, et al. Recommendations for standardized human pedigree nomenclature Pedigree Standardization Task Force of the National Society of Genetic Counselors. Am J Hum Genet 1995; 56: 745–52, [PUBMED], [INFOTRIEVE], [CSA]
- Moldin S O. Psychiatric genetic counseling. Washington University Adult Psychiatry, S B Guze. Mosby, St. Louis, MO 1997; 365–381
- Smoller J W, Finn C T, White C A. The genetics of anxiety disorders: an overview. Psychiatr Ann 2000; 30: 745–53, [CSA]
- Tsuang M T, Stone W S, Faraone S V. Genes, environment and schizophrenia. Br J Psychiatry 2001; l178: S18–24, [CSA]
- Tsuang M. Schizophrenia: genes and environment. Biol Psychiatry 2000; 47: 210–20, [PUBMED], [INFOTRIEVE], [CSA]
- Hettema J M, Neale M C, Kendler K S. A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry 2001; 158: 1568–78, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Sullivan P F, Neale M C, Kendler K S. Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry 2000; 157: 1552–62, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Folstein S E, Rosen-Sheidley B. Genetics of autism: complex aetiology for a heterogeneous disorder. Nat Rev Genet 2001; 2: 943–55, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Harper P S. Practical genetic counseling. Butterworth-Heinemann, Oxford, Boston 1998
- McGuffin P, Owen M J, Gottesman I I. Psychiatric genetics and genomics. Oxford University Press, Oxford, New York 2002
- Andreasen N C, Rice J, Endicott J, Reich T, Coryell W. The family history approach to diagnosis. How useful is it? Arch Gen Psychiatry 1986; 43: 421–9, [CSA]
- Bolton P, Macdonald H, Pickles A, et al. A case-control family history study of autism. J Child Psychol Psychiatry 1994; 35: 877–900, [PUBMED], [INFOTRIEVE], [CSA]
- Landa R, Piven J, Wzorek M M, Gayle J O, Chase G A, Folstein S E. Social language use in parents of autistic individuals. Psychol Med 1992; 22: 245–54, [PUBMED], [INFOTRIEVE], [CSA]
- Weissman M M, Wickramaratne P, Merikangas K R, et al. Onset of major depression in early adulthood. Increased familial loading and specificity. Arch Gen Psychiatry 1984; 41: 1136–43, [PUBMED], [INFOTRIEVE], [CSA]
- Lord C, Schopler E, Revicki D. Sex differences in autism. J Autism Dev Disord 1982; 12: 317–30, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Smalley S L, Asarnow R F, Spence M A. Autism and genetics. A decade of research. Arch Gen Psychiatry 1988; 45: 953–61, [PUBMED], [INFOTRIEVE], [CSA]
- Weissman M M, Wickramaratne P, Nomura Y, et al. Families at high and low risk for depression: a 3-generation study. Arch Gen Psychiatry 2005; 62: 29–36, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Gigerenzer G, Edwards A. Simple tools for understanding risks: from innumeracy to insight. BMJ 2003; 327: 741–4, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Forrow L, Taylor W C, Arnold R M. Absolutely relative: how research results are summarized can affect treatment decisions. Am J Med 1992; 92: 121–4, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Guttmacher A E, Collins F S. Welcome to the genomic era. N Engl J Med 2003; 349: 996–8, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Khoury M J. Genetics and genomics in practice: the continuum from genetic disease to genetic information in health and disease. Genet Med 2003; 5: 261–8, [PUBMED], [INFOTRIEVE], [CSA]
- Meiser B, Dunn S. Psychological impact of genetic testing for Huntington's disease: an update of the literature. J Neurol Neurosurg Psychiatry 2000; 69: 574–8, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Kessler S, Field T, Worth L, Mosbarger H. Attitudes of persons at risk for Huntington disease toward predictive testing. Am J Med Genet 1987; 26: 259–70, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Evers-Kiebooms G, Decruyenaere M. Predictive testing for Huntington's disease: a challenge for persons at risk and for professionals. Patient Educ Couns 1998; 35: 15–26, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- McDonald-McGinn D M, LaRossa D, Goldmuntz E, et al. The 22q11.2 deletion: screening, diagnostic workup, and outcome of results; report on 181 patients. Genet Test 1997; l1: 99–108, [CSA]
- Ryan A K, Goodship J A, Wilson D I, et al. Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study. J Med Genet 1997; 34: 798–804, [PUBMED], [INFOTRIEVE], [CSA]
- Shprintzen R J. Velo-cardio-facial syndrome: a distinctive behavioral phenotype. Ment Retard Dev Disabil Res Rev 2000; 6: 142–7, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Pulver A E, Nestadt G, Goldberg R, et al. Psychotic illness in patients diagnosed with velo-cardio-facial syndrome and their relatives. J Nerv Ment Dis 1994; 182: 476–8, [PUBMED], [INFOTRIEVE], [CSA]
- Papolos D F, Faedda G L, Veit S, et al. Bipolar spectrum disorders in patients diagnosed with velo-cardio-facial syndrome: does a hemizygous deletion of chromosome 22q11 result in bipolar affective disorder?. Am J Psychiatry 1996; l153: 1541–7, [CSA]
- Murphy K C, Jones L A, Owen M J. High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry 1999; 56: 940–5, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Bassett A S, Chow E W, Abdel Malik P, Gheorghiu M, Husted J, Weksberg R. The schizophrenia phenotype in 22q11 deletion syndrome. Am J Psychiatry 2003; 160: 1580–6, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Murphy K C, Owen M J. Velo-cardio-facial syndrome: a model for understanding the genetics and pathogenesis of schizophrenia. Br J Psychiatry 2001; 179: 397–402, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Inoue K, Lupski J R. Genetics and genomics of behavioral and psychiatric disorders. Curr Opin Genet Dev 2003; 13: 303–9, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Finn C T, Stoler J M, Smoller J W. Genetics and genetic disorders. Massachusetts General Hospital handbook of general hospital psychiatry, N H Cassem, T A Stern, J R Rosenbaum, M S Jellinek. Mosby, St. Louis, MO 2003
- Kaufman J, Yang B Z, Douglas-Palumberi H, et al. Social supports and serotonin transporter gene moderate depression in maltreated children. Proc Natl Acad Sci U S A 2004; 101: 17316–21, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Kendler K S, Kuhn J W, Vittum J, Prescott C A, Riley B. The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression: a replication. Arch Gen Psychiatry 2005; 62: 529–35, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Eley T C, Sugden K, Corsico A, et al. Gene-environment interaction analysis of serotonin system markers with adolescent depression. Mol Psychiatry 2004; 9: 908–15, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Bird T D, Sumi S M, Nemens E J, et al. Phenotypic heterogeneity in familial Alzheimer's disease: a study of 24 kindreds. Ann Neurol 1989; 25: 12–25, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Bertram L, Tanzi R E. The current status of Alzheimer's disease genetics: what do we tell the patients?. Pharmacol Res 2004; 50: 385–96, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Relkin N R, Kwon Y J, Tsai J, Gandy S. The National Institute on Aging/Alzheimer's Association recommendations on the application of apolipoprotein E genotyping to Alzheimer's disease. Ann N Y Acad Sci 1996; 802: 149–76, [PUBMED], [INFOTRIEVE], [CSA]
- Post S G, Whitehouse P J, Binstock R H, et al. The clinical introduction of genetic testing for Alzheimer disease. An ethical perspective. JAMA 1997; 277: 832–6, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Roberts J S, Barber M, Brown T M, et al. Who seeks genetic susceptibility testing for Alzheimer's disease? Findings from a multisite, randomized clinical trial. Genet Med 2004; l6: 197–203, [CSA]
- Humphries S E, Ridker P M, Talmud P J. Genetic testing for cardiovascular disease susceptibility: a useful clinical management tool or possible misinformation?. Arterioscler Thromb Vasc Biol 2004; 24: 628–36, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Evans J P, Skrzynia C, Burke W. The complexities of predictive genetic testing. BMJ 2001; 322: 1052–6, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Yang Q, Khoury M J, Botto L, Friedman J M, Flanders W D. Improving the prediction of complex diseases by testing for multiple disease-susceptibility genes. Am J Hum Genet 2003; 72: 636–49, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Yamada Y, Izawa H, Ichihara S, et al. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med 2002; 347: 1916–23, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Harper P S. Insurance and genetic testing. Lancet 1993; 341: 224–7, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Cunningham G C. The genetics revolution. Ethical, legal, and insurance concerns. Postgrad Med 2000; l108: 193–6, 199–200, 202[CSA]
- Annas G J. The limits of state laws to protect genetic information. N Engl J Med 2001; 345: 385–8, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]